Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist in pre-menopausal women to treat severe polycystic liver disease
2020-005949-16Phase 2Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of leuprolide in Polycystic liver disease (PLD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Liver growth rate. Started Oct 2021; status: active.
02
Drugs
leuprolide
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on 2020-005949-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005949-16.